<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We used a new combined chemo- (COP/ABVD), radiation and interferon-alpha (10 x 10(6) IU s.c </plain></SENT>
<SENT sid="1" pm="."><plain>3x per week/12 months) therapy regimen to treat severe <z:e sem="disease" ids="C1334815" disease_type="Neoplastic Process" abbrv="">multicentric Castleman's disease</z:e> (CD) complicated by relapsing <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) manifestations </plain></SENT>
<SENT sid="2" pm="."><plain>More than 16 years after diagnosis of CD the patient remains in very good clinical condition, with remission of <z:hpo ids='HP_0000001'>all</z:hpo> CD and BD manifestations 13 months after discontinuation of the interferon-alpha treatment </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, our clinicopathological, immunohistological and virological data suggest a pathogenetic link between CD and BD via activation of pre-existing BD-specific plasma cells due to CD-related HHV8-induced overexpression of interleukin-6 </plain></SENT>
</text></document>